Pharma Specialty BU Director — Strategy, Growth & Leadership

MSD; Österreich; Hybrid; GBP 93,000 - 119,000; Full time

Benefits offered by this job

Excellent social benefits

Hybrid work environment

International exposure

Job summary

MSD seeks a Business Unit Director for Pharma Specialty to lead the Austria/Switzerland portfolio with end-to-end accountability for strategy, performance, and people. The role shapes enterprise leadership, cross-functional collaboration, and market access across regional priorities.

The ideal candidate has 10+ years of senior pharma leadership, proven P&L ownership, and success in brand lifecycle management, omnichannel digital commercialization, and international leadership.

Qualifications

• University degree in biosciences or business; MBA or PhD preferred.
• 10+ years of senior leadership experience in the pharmaceutical/biotech industry.
• Proven P&L ownership and delivery of sustained business results.
• Experience leading in matrixed, international environments.

Responsibilities

• Own full P&L accountability for the Business Unit, driving revenue and profitability.
• Develop and execute long-term strategy, LROP, and operating/financial plans aligned with priorities.
• Lead end-to-end commercialization, brand strategy, and digital engagement initiatives.
• Drive forecast accuracy, supply coordination, and launch readiness while ensuring ethical labeling.
• Build and develop a high-performing, diverse leadership team and culture of accountability.

Skills

P&L ownership

Brand & portfolio management

Product launch

Omnichannel & digital

Leadership

Stakeholder management

Fluent English

German language

Education

MBA or PhD preferred

Job description

MSD seeks a Business Unit Director for Pharma Specialty to lead the Austria/Switzerland portfolio with end-to-end accountability for strategy, performance, and people. The role shapes enterprise leadership, cross-functional collaboration, and market access across regional priorities.

The ideal candidate has 10+ years of senior pharma leadership, proven P&L ownership, and success in brand lifecycle management, omnichannel digital commercialization, and international leadership.